• Watson Pharmaceuticals Inc., of Parsippany, N.J., said the FDA approved its abbreviated new drug application for Next Choice One Dose (levonorgestrel tablet, 1.5 mg), the generic equivalent to Jerusalem-based Teva Pharmaceutical Industries Ltd.'s Plan B One-Step. Watson plans to launch immediately.